Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/24541
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJayawardane, I.A.
dc.contributor.authorPiyadigama, I.
dc.contributor.authorSolangaarachchi, H.
dc.contributor.authorWilliams, S.
dc.date.accessioned2022-03-24T09:51:00Z
dc.date.available2022-03-24T09:51:00Z
dc.date.issued2021
dc.identifier.citationSri Lanka Journal of Obstetrics and Gynaecology.2021;43(4):322–325.en_US
dc.identifier.issn2279-1655
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/24541
dc.description.abstractA 24-weeks pregnant woman in her 2nd pregnancy presented with mild COVID symptoms and new onset rapidly progressive severe thrombocytopenia with a nadir of 20×109/L. She did not have any bleeding manifestations and the platelet counts recovered over 3 days without the need of steroids or immunoglobulin treatment. COVID-19 infection may cause transient severe thrombocytopenia, and this has not been previously reported in second trimester of pregnancy. We speculate the cause to be immune mediated. Other causes for severe thrombocytopenia were excluded after comprehensive investigations. This raise concerns on thromboprophylaxis and anticoagulant use in early pregnancies infected with COVID-19. Assessing the platelet counts at least two occasions few days apart of an infected patient may be a safer approach if continuing anticoagulants.en_US
dc.language.isoenen_US
dc.publisherSri Lanka college of Obstetricians & Gynaecologistsen_US
dc.subjectSevere thrombocytopeniaen_US
dc.subjectCOVID-19en_US
dc.titleTransient severe thrombocytopenia with SARS-Cov-2 (COVID-19) infection in pregnancyen_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
8028-28418-1-PB.pdf82.54 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.